Literature DB >> 29564567

T-bet deficiency attenuates cardiac remodelling in rats.

Zhen-Guo Ma1,2,3, Jia Dai1,2,3, Yu-Pei Yuan1,2,3, Zhou-Yan Bian1,2,3, Si-Chi Xu1,2,3, Ya-Ge Jin1,2,3, Xin Zhang1,2,3, Qi-Zhu Tang4,5,6.   

Abstract

Previous studies have suggested the involvement of CD4 + T lymphocytes in cardiac remodelling. T-bet can direct Th1 lineage commitment. This study aimed to investigate the functional significance of T-bet in cardiac remodelling induced by pressure overload using T-bet global knockout rats. Increased T-bet levels were observed in rodent and human hypertrophied hearts. T-bet deficiency resulted in a less severe hypertrophic phenotype in rats. CD4 + T-lymphocyte reconstitution in T-bet-/- rats resulted in aggravated cardiac remodelling. T-cell homing molecule expression and cytokine secretion were altered in T-bet-deficient rat hearts. Administration of exogenous interferon-γ (IFN-γ) offset T-bet deficiency-mediated cardioprotection. Cardiomyocytes cultured in T-bet-/- CD4 + T-cell-conditioned media showed a reduced hypertrophic response after hypertrophic stimuli, which was abolished by an IFN-γ-neutralizing antibody. Taken together, our findings show that T-bet deficiency attenuates pressure overload-induced cardiac remodelling in rats. Specifically, targeting T-bet in T cells may be of great importance for the treatment of pathological cardiac remodelling and heart failure.

Entities:  

Keywords:  Cardiac remodelling; Interferon-γ; T helper subset; T lymphocytes; T-bet

Mesh:

Substances:

Year:  2018        PMID: 29564567     DOI: 10.1007/s00395-018-0678-x

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  29 in total

Review 1.  Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.

Authors:  Ioanna Andreadou; Hector A Cabrera-Fuentes; Yvan Devaux; Nikolaos G Frangogiannis; Stefan Frantz; Tomasz Guzik; Elisa A Liehn; Clarissa P C Gomes; Rainer Schulz; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

2.  The heart under pressure: immune cells in fibrotic remodeling.

Authors:  Brandon Theall; Pilar Alcaide
Journal:  Curr Opin Physiol       Date:  2022-01-22

3.  Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

Authors:  Xin Zhang; Can Hu; Hai-Ming Wu; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

Review 4.  Adding insult to injury - Inflammation at the heart of cardiac fibrosis.

Authors:  Sasha Smolgovsky; Udoka Ibeh; Tatiana Peña Tamayo; Pilar Alcaide
Journal:  Cell Signal       Date:  2020-11-06       Impact factor: 4.315

5.  Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism.

Authors:  Xin Zhang; Can Hu; Yu-Pei Yuan; Peng Song; Chun-Yan Kong; Hai-Ming Wu; Si-Chi Xu; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Cell Biol Toxicol       Date:  2021-01-20       Impact factor: 6.691

6.  Asiatic Acid Protects against Doxorubicin-Induced Cardiotoxicity in Mice.

Authors:  Xiaoping Hu; Baijun Li; Luocheng Li; Bowen Li; Jinlong Luo; Bin Shen
Journal:  Oxid Med Cell Longev       Date:  2020-05-15       Impact factor: 6.543

7.  FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.

Authors:  Xin Zhang; Can Hu; Chun-Yan Kong; Peng Song; Hai-Ming Wu; Si-Chi Xu; Yu-Pei Yuan; Wei Deng; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Cell Death Differ       Date:  2019-06-17       Impact factor: 15.828

Review 8.  Inflammatory Cytokines, Immune Cells, and Organ Interactions in Heart Failure.

Authors:  Huihui Li; Chen Chen; Dao Wen Wang
Journal:  Front Physiol       Date:  2021-07-01       Impact factor: 4.566

9.  Osteocrin, a novel myokine, prevents diabetic cardiomyopathy via restoring proteasomal activity.

Authors:  Xin Zhang; Can Hu; Xiao-Pin Yuan; Yu-Pei Yuan; Peng Song; Chun-Yan Kong; Teng Teng; Min Hu; Si-Chi Xu; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Cell Death Dis       Date:  2021-06-16       Impact factor: 8.469

10.  Tetrandrine Attenuated Doxorubicin-Induced Acute Cardiac Injury in Mice.

Authors:  Gang Li; Wen-Rui Li; Ya-Ge Jin; Qi-Qiang Jie; Cheng-Yu Wang; Lin Wu
Journal:  Biomed Res Int       Date:  2020-05-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.